Cargando…

Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies

Lipoprotein(a) (Lp(a)) is an established risk factor for multiple cardiovascular diseases. Several lines of evidence including mechanistic, epidemiologic, and genetic studies support the role of Lp(a) as a causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis/calc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatia, Harpreet S., Wilkinson, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604626/ https://www.ncbi.nlm.nih.gov/pubmed/36294361 http://dx.doi.org/10.3390/jcm11206040

Ejemplares similares

Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease
por: Tada, Hayato, et al.
Publicado: (2019)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
por: Toth, Peter P
Publicado: (2016)

Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction
por: Enas, Enas A., et al.
Publicado: (2019)

Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?
por: Vavlukis, Marija
Publicado: (2017)

Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases
por: Gao, Qiannan, et al.
Publicado: (2022)

Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
por: Kronenberg, Florian
Publicado: (2016)

Lipoprotein(a): the underutilized risk factor for cardiovascular disease
por: Khan, TZ, et al.
Publicado: (2019)

Lipoprotein (a): A Novel Cardiovascular Risk Factor
por: Kozarova, Miriam, et al.
Publicado: (2023)

Lipoprotein (a) and cardiovascular risk factors in children and adolescents
por: Palmeira, Ástrid Camêlo, et al.
Publicado: (2013)

Lipoprotein(a) as a cardiovascular risk factor: current status
por: Nordestgaard, Børge G., et al.
Publicado: (2010)

Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects
por: Schmitz, Gerd, et al.
Publicado: (2015)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives
por: Vinci, Pierandrea, et al.
Publicado: (2023)

Evidence and Uncertainties on Lipoprotein(a) as a Marker of Cardiovascular Health Risk in Children and Adolescents
por: Genovesi, Simonetta, et al.
Publicado: (2023)

Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
por: Huang, Jih-Kai, et al.
Publicado: (2022)

A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies
por: Vekic, Jelena, et al.
Publicado: (2022)

Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States
por: Bhatia, Harpreet S., et al.
Publicado: (2023)

The Role of Emerging Risk Factors in Cardiovascular Outcomes
por: Lacey, Ben, et al.
Publicado: (2017)

Using genetic variation for establishing causality of cardiovascular risk factors: overcoming confounding and reverse causality
por: Smit, R. A. J., et al.
Publicado: (2014)

Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes
por: Ma, Gary S., et al.
Publicado: (2023)

The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease
por: Gabani, Mohanad, et al.
Publicado: (2023)

Lipoprotein(a) in Cardiovascular Diseases
por: Malaguarnera, Michele, et al.
Publicado: (2013)

Lipoprotein (a), an independent cardiovascular risk marker
por: Saeedi, Ramesh, et al.
Publicado: (2016)

Tamoxifen, serum lipoproteins and cardiovascular risk.
por: Bruning, P. F., et al.
Publicado: (1988)

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
por: Wilkinson, Michael J., et al.
Publicado: (2023)

High density lipoproteins-based therapies for cardiovascular disease
por: Gao, Xuan, et al.
Publicado: (2010)

Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk
por: Colley, Kenneth J., et al.
Publicado: (2011)

Is there a benefit of aspirin therapy for primary prevention to reduce the risk of atherosclerotic cardiovascular disease in patients with elevated Lipoprotein (a)—A review of the evidence
por: Sukkari, Mohamad Hekmat, et al.
Publicado: (2023)

Postprandial Lipoproteins and Cardiovascular Disease Risk in Diabetes Mellitus
por: Enkhmaa, Byambaa, et al.
Publicado: (2010)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?
por: Gaffo, Angelo L, et al.
Publicado: (2009)

Age- and Sex-Specific Causal Effects of Adiposity on Cardiovascular Risk Factors
por: Fall, Tove, et al.
Publicado: (2015)

Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Lipoprotein(a) and diet—a challenge for a role of saturated fat in cardiovascular disease risk reduction?
por: Law, Hayley G., et al.
Publicado: (2023)

Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review
por: Watanabe, Jun, et al.
Publicado: (2020)

Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease
por: Herrington, William, et al.
Publicado: (2017)

Is High-Density Lipoprotein Cholesterol Causally Related to Kidney Function?: Evidence From Genetic Epidemiological Studies
por: Coassin, Stefan, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
por: Brouwers, Martijn C. G. J., et al.
Publicado: (2019)

Does Sufficient Evidence Exist to Support a Causal Association between Vitamin D Status and Cardiovascular Disease Risk? An Assessment Using Hill’s Criteria for Causality
por: Weyland, Patricia G., et al.
Publicado: (2014)

Lipoprotein(a) Interactions With Low‐Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS)
por: Afshar, Mehdi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_teg8heceudsut8n2ai2khrkb22